Expert Perspectives Post Conference Highlights on MASLD/MASH from AASLD

Wednesday, November 27, 2024, 8:00 AM - Thursday, November 27, 2025, 11:59 PM

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)


The archived series will feature four recorded livestream events, with one following each of the major liver congresses found in the below graphic. The content will be derived from a review of the current literature and abstracts presented at each of these congresses with the livestreams providing an overview of the evolving management and treatment of MASLD/MASH, with a focus on the emerging data presented at each of the congress meetings. Expert faculty presenters will provide their perspectives on how the data will impact the care and treatment of patients with MASLD/MASH.

There are no fees for participating in and receiving CME credit for this activity. 

1. Discuss emerging data on NIT utilization for the diagnosis and monitoring of MASH;
2. Analyze current and potential pharmacologic management strategies for MASH, including GLP-1 agonists;
3. Integrate weight loss into MASLD/MASH disease management strategies.

Accreditation & Designation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, the Gi Health Foundation, in collaboration with Gastroenterology & Hepatology Advanced Practice Providers. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Disclaimer Statement
The opinions expressed during this activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati or CORE Medical Education. The information is presented for the purpose of advancing the attendees’ professional development.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati nor CORE Medical Education, LLC, recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

COI / Disclosure of Relationships with Ineligible Entities

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

*Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant relationships have been mitigated. The following disclosures were made:

Planning Members

Rachel Bejarano, PharmD - Medical Writer
Nothing to disclose

Lisa Pedicone, PhD - Medical Writer
Nothing to disclose

Speakers

Joseph Ahn, MD
Speaker - Madrigal (ended 10/2024)

Ann Moore, NP
Consultant - Cymabay
Consultant/Speaker/Research - AbbVie, Gilead, GSK, Ipsen, Madrigal, Novo Nordisk

Nancy Reau, MD
Consultant - Mallinckrodt, VIR
Consultant/Research - Gilead, Salix
Consultant/DMB - Arbutus

All additional planning committee members, the University of Cincinnati staff and The Chronic Liver Disease Foundation (CLDF), and Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) staff have no relationships to disclose.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

This educational activity is supported by an educational grant from Novo Nordisk.